Check-Cap Sets 1-for-7 Reverse Split Effective August 12 to Support Nasdaq Compliance and Merger
MBAI has more than doubled off its 52-week low of $0.6.
Summary
Check-Cap announced a 1-for-7 reverse stock split effective August 12, 2026, reducing outstanding shares to approximately 1.35 million. The split supports Nasdaq compliance and the pending merger with MBody AI, expected to close by end of Q3 2026.
Key Events · Corporate Governance and Compliance · MBAI
-
1-for-7 Reverse Split Announced
Effective August 12, 2026, every seven shares will be consolidated into one, cutting the outstanding count from roughly 9.46 million to about 1.35 million.
-
Nasdaq Compliance and Merger Support
The reverse split is designed to maintain Nasdaq listing requirements and facilitate the pending merger with MBody AI, expected to close by end of Q3 2026.
-
Shareholder Approval Obtained in 2025
Shareholders approved the reverse split at the Annual General Meeting on November 14, 2025, with the board setting the ratio on July 31, 2026.
-
No Fractional Shares; Rounding Up
Fractional shares resulting from the split will be rounded up to the nearest whole share, with no action required from shareholders.
Analysis · MBAI · Industrial Applications And Services
To maintain its Nasdaq listing and pave the way for the MBody AI merger, Check-Cap is executing a 1-for-7 reverse stock split that will shrink outstanding shares from roughly 9.46 million to about 1.35 million. The move takes effect on August 12, 2026—just days after the announcement—and follows shareholder approval secured in November 2025. It is a critical technical step in the company's broader transformation into embodied AI and robotics, with the merger expected to close by the end of Q3 2026. While reverse splits often carry a negative stigma, this one is a necessary adjustment to support the strategic pivot.
At the time of this filing, MBAI was trading at $1.35 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $9.9M. The 52-week trading range was $0.60 to $3.92. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.